Related content

Whole body physiologically-based pharmacokinetic models: their use in clinical drug development

By Edginton Andrea N   Theil Frank-Peter   Schmitt Walter   Willmann Stefan  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1143-1152

Informa Healthcare

Access to resources Recommend Favorite

Diazepam Pharamacokinetics from Preclinical to Phase I Using a Bayesian Population Physiologically Based Pharmacokinetic Model with Informative Prior Distributions in Winbugs

By Gueorguieva Ivelina   Aarons Leon   Rowland Malcolm  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 33, Iss. 5, 2006-10 ,pp. : 571-594

Springer Publishing Company

Access to resources Recommend Favorite

Reducing Whole Body Physiologically Based Pharmacokinetic Models Using Global Sensitivity Analysis: Diazepam Case Study

By Gueorguieva Ivelina   Nestorov Ivan   Rowland Malcolm  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 33, Iss. 1, 2006-02 ,pp. : 1-27

Springer Publishing Company

Access to resources Recommend Favorite

Defining the Role of Macrophages in Local Moxifloxacin Tissue Concentrations using Biopsy Data and Whole-Body Physiologically Based Pharmacokinetic Modelling

By Edginton Andrea N.  

Clinical Pharmacokinetics, Vol. 48, Iss. 3, 2009-01 ,pp. : 181-187

Adis International

Access to resources Recommend Favorite

Whole Body Pharmacokinetic Models

By Nestorov I.  

Clinical Pharmacokinetics, Vol. 42, Iss. 10, 2003-01 ,pp. : 883-908

Adis International

Access to resources Recommend Favorite